General Information
Version
3.0
Revision date
2023-11-15
Product name
LAURYL SULFATE DE SODIUM PH 11 (LAURITOL S-HPH)
CAS No.
85586-07-8
REACH No
01-2119489463-28
1.2.1 Relevant identified uses
formulation of detergent, industrial auxiliaire
Icons in SDS
Company Information
company name
INTERCHIMIE
e-mail address of the competent person responsible for the Safety Data Sheet
qualite@interchimie.fr
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful if swallowed. Causes skin irritation. Causes serious eye damage. Harmful to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05
Signal word
Danger
Contains
Sulfuric acid, mono-C12-14-alkyl esters, sodium salts
Hazard statements
H315 - Causes skin irritation. H318 - Causes serious eye damage. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P280 - Wear eye protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Sulfuric acid, mono-C12-14-alkyl esters, sodium salts This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (85586-07-8) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %